Advertisement
Screener

Avantor, Inc. (AVTR) Gain (Loss) on Extinguishment of Debt

Avantor, Inc. Gain (Loss) on Extinguishment of Debt

Avantor, Inc. (AVTR) reported Gain (Loss) on Extinguishment of Debt of -$600.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-04-29

  • Avantor, Inc. gain (loss) on extinguishment of debt for the quarter ending 2026-03-31 was -$600.00K.
  • Avantor, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was -$4.40M.
  • Avantor, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was -$200.00K.
  • Avantor, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
  • Avantor, Inc. gain (loss) on extinguishment of debt for fiscal 2025 was -$4.60M.
  • Avantor, Inc. gain (loss) on extinguishment of debt for fiscal 2024 was -$10.90M.
  • Avantor, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was -$6.90M.
  • Avantor, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was -$12.50M.
Period endGain (Loss) on Extinguishment of Debt 3 monthGain (Loss) on Extinguishment of Debt 6 monthGain (Loss) on Extinguishment of Debt 9 monthGain (Loss) on Extinguishment of Debt 12 month
2026-03-31-$600.00K
10-Q · filed 2026-04-29
-$5.00M
derived: sum of 2 quarters · filed 2026-04-29
-$5.20M
derived: sum of 3 quarters · filed 2026-04-29
-$5.20M
derived: sum of 4 quarters · filed 2026-04-29
2025-12-31-$4.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
-$4.60M
derived: sum of 2 quarters · filed 2026-02-11
-$4.60M
derived: sum of 3 quarters · filed 2026-02-11
-$4.60M
10-K · filed 2026-02-11
2025-09-30-$200.00K
10-Q · filed 2025-10-29
-$200.00K
derived: sum of 2 quarters · filed 2025-10-29
-$200.00K
10-Q · filed 2025-10-29
-$4.60M
derived: sum of 4 quarters · filed 2026-04-29
2025-06-30$0.00
10-Q · filed 2025-08-01
$0.00
10-Q · filed 2025-08-01
-$4.40M
derived: sum of 3 quarters · filed 2026-04-29
-$6.50M
derived: sum of 4 quarters · filed 2026-04-29
2025-03-31$0.00
10-Q · filed 2026-04-29
-$4.40M
derived: sum of 2 quarters · filed 2026-04-29
-$6.50M
derived: sum of 3 quarters · filed 2026-04-29
-$8.40M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31-$4.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
-$6.50M
derived: sum of 2 quarters · filed 2026-02-11
-$8.40M
derived: sum of 3 quarters · filed 2026-02-11
-$10.90M
10-K · filed 2026-02-11
2024-09-30-$2.10M
10-Q · filed 2025-10-29
-$4.00M
derived: sum of 2 quarters · filed 2025-10-29
-$6.50M
10-Q · filed 2025-10-29
-$7.50M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30-$1.90M
10-Q · filed 2025-08-01
-$4.40M
10-Q · filed 2025-08-01
-$5.40M
derived: sum of 3 quarters · filed 2026-02-11
-$7.40M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31-$2.50M
10-Q · filed 2025-04-25
-$3.50M
derived: sum of 2 quarters · filed 2026-02-11
-$5.50M
derived: sum of 3 quarters · filed 2026-02-11
-$7.10M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
-$3.00M
derived: sum of 2 quarters · filed 2026-02-11
-$4.60M
derived: sum of 3 quarters · filed 2026-02-11
-$6.90M
10-K · filed 2026-02-11
2023-09-30-$2.00M
10-Q · filed 2024-10-25
-$3.60M
derived: sum of 2 quarters · filed 2024-10-25
-$5.90M
10-Q · filed 2024-10-25
-$7.60M
derived: sum of 4 quarters · filed 2025-02-07
2023-06-30-$1.60M
10-Q · filed 2024-07-26
-$3.90M
10-Q · filed 2024-07-26
-$5.60M
derived: sum of 3 quarters · filed 2025-02-07
-$8.50M
derived: sum of 4 quarters · filed 2025-02-07
2023-03-31-$2.30M
10-Q · filed 2024-04-26
-$4.00M
derived: sum of 2 quarters · filed 2025-02-07
-$6.90M
derived: sum of 3 quarters · filed 2025-02-07
-$13.00M
derived: sum of 4 quarters · filed 2025-02-07
2022-12-31-$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07
-$4.60M
derived: sum of 2 quarters · filed 2025-02-07
-$10.70M
derived: sum of 3 quarters · filed 2025-02-07
-$12.50M
10-K · filed 2025-02-07
2022-09-30-$2.90M
10-Q · filed 2023-10-27
-$9.00M
derived: sum of 2 quarters · filed 2023-10-27
-$10.80M
10-Q · filed 2023-10-27
-$14.80M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30-$6.10M
10-Q · filed 2023-07-28
-$7.90M
10-Q · filed 2023-07-28
-$11.90M
derived: sum of 3 quarters · filed 2024-02-14
-$11.90M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31-$1.80M
10-Q · filed 2023-04-28
-$5.80M
derived: sum of 2 quarters · filed 2024-02-14
-$5.80M
derived: sum of 3 quarters · filed 2024-02-14
-$9.00M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31-$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
-$4.00M
derived: sum of 2 quarters · filed 2024-02-14
-$7.20M
derived: sum of 3 quarters · filed 2024-02-14
-$12.40M
10-K · filed 2024-02-14
2021-09-30$0.00
10-Q · filed 2022-10-28
-$3.20M
derived: sum of 2 quarters · filed 2022-10-28
-$8.40M
10-Q · filed 2022-10-28
-$128.80M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30-$3.20M
10-Q · filed 2022-07-29
-$8.40M
10-Q · filed 2022-07-29
-$128.80M
derived: sum of 3 quarters · filed 2023-02-14
-$355.20M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31-$5.20M
10-Q · filed 2022-04-29
-$125.60M
derived: sum of 2 quarters · filed 2023-02-14
-$352.00M
derived: sum of 3 quarters · filed 2023-02-14
-$352.00M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31-$120.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
-$346.80M
derived: sum of 2 quarters · filed 2023-02-14
-$346.80M
derived: sum of 3 quarters · filed 2023-02-14
-$346.80M
10-K · filed 2023-02-14
2020-09-30-$226.40M
10-Q · filed 2021-10-29
-$226.40M
derived: sum of 2 quarters · filed 2021-10-29
-$226.40M
10-Q · filed 2021-10-29
-$229.90M
derived: sum of 4 quarters · filed 2022-02-11
2020-06-30$0.00
10-Q · filed 2021-07-30
$0.00
10-Q · filed 2021-07-30
-$3.50M
derived: sum of 3 quarters · filed 2022-02-11
-$3.50M
derived: sum of 4 quarters · filed 2022-02-11
2020-03-31$0.00
10-Q · filed 2021-04-28
-$3.50M
derived: sum of 2 quarters · filed 2022-02-11
-$3.50M
derived: sum of 3 quarters · filed 2022-02-11
-$73.70M
derived: sum of 4 quarters · filed 2022-02-11
2019-12-31-$3.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11
-$3.50M
derived: sum of 2 quarters · filed 2022-02-11
-$73.70M
derived: sum of 3 quarters · filed 2022-02-11
-$73.70M
10-K · filed 2022-02-11
2019-09-30$0.00
10-Q · filed 2020-10-27
-$70.20M
derived: sum of 2 quarters · filed 2020-10-27
-$70.20M
10-Q · filed 2020-10-27
2019-06-30-$70.20M
10-Q · filed 2020-07-29
-$70.20M
10-Q · filed 2020-07-29
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$0.00
derived: sum of 2 quarters · filed 2021-02-16
$0.00
derived: sum of 3 quarters · filed 2021-02-16
$0.00
10-K · filed 2021-02-16
2018-09-30$0.00
10-Q · filed 2019-11-05
$0.00
derived: sum of 2 quarters · filed 2019-11-05
$0.00
10-Q · filed 2019-11-05
2018-06-30$0.00
10-Q · filed 2019-08-06
$0.00
10-Q · filed 2019-08-06
2017-12-31-$56.40M
10-K · filed 2020-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRUKER CORP (BRKR)United States$9.706B-128.75
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34